ArticleBreast cancer research and treatment2020

The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer.

Sudpreeda Chainitikun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.